RecruitingNot ApplicableNCT05206292
Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders.
Sponsor
University Hospital, Grenoble
Enrollment
600 participants
Start Date
Jan 12, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Screening for sulfur amino acid metabolism pathologies using a sulfitest in adult patients with psychotic disorder.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Male or female 18 years of age and older,
- Followed for a psychotic disorder,
- With no known organic etiology for the psychotic disorder,
- Not having formulated its opposition to participation in the study (or his/her tutor/curator),
- Affiliated with the social security system.
Exclusion Criteria1
- Patients protected by law (minors, pregnant or breastfeeding women, deprived of liberty or hospitalized under constraint, under administrative or judicial supervision) except patients under tutorship or curatorship.
Interventions
DIAGNOSTIC_TESTSulfitest
Urine strip to detect the presence of sulfites in urine. Immediate result.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05206292
Related Trials
Tolerability of MDMA in Schizophrenia
NCT057703751 location
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
NCT037940761 location
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
NCT0688278555 locations
Cerebellar Modulation of Cognition in Psychosis
NCT061077642 locations